title: Thyroid: nuclear medicine update.
abstract: Nuclear medicine has been used in the evaluation and treatment of benign and malignant thyroid disease since the discovery of iodine 131 ((131)I) in the 1930s. Although traditional methods of imaging are routinely used, recent advancements such as SPECT/CT and PET/CT have greatly enhanced the ability of nuclear medicine to accurately detect and localize. Guidelines for the management of thyroid cancer continue to evolve, treatment regimens selected should balance the long-term risk of disease recurrence and cumulative risks of radiation exposure, and physicians should be aware of these updates and guidelines when caring for patients with thyroid disease.
authors.affiliation: Division of Nuclear Medicine, Department of Radiology, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA. joycejm@upmc.edu
authors.forename: Judith M
authors.initials: JM
authors.lastname: Joyce
authors.forename: Andrew
authors.initials: A
authors.lastname: Swihart
mesh_terms: D019788:Fluorodeoxyglucose F18; D015902:Gamma Cameras; D006801:Humans; D007457:Iodine Radioisotopes; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals; D013670:Sodium Pertechnetate Tc 99m; D013959:Thyroid Diseases / Q000000981:diagnostic imaging*; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed
chemical_list: D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D013670:Sodium Pertechnetate Tc 99m